Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk Shares Climb
Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died
Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs.
Novo Nordisk Shares Climb as Wegovy Sales Reassure Investors
Novo Nordisk A/S shares rose as surging sales of the blockbuster weight-loss treatment Wegovy reassured investors after rival Eli Lilly & Co. reported disappointing sales of its obesity treatment last week.
Novo Nordisk’s Blockbuster Wegovy Drug Sales Beat Expectations
The company narrowed its full-year guidance as its blockbuster weight-loss drug soars in popularity.
10h
Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns
Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...
Investopedia on MSN
14h
Novo Nordisk Stock Slips as Sales Grow Less Than Expected
After rising in premarket trading, Novo Nordisk's U.S.-listed shares fell after the market opened Wednesday as its ...
FierceBiotech
1d
Novo Nordisk discards kidney disease drug from $1.3B deal in wake of phase 3 fail
Novo
Nordisk
, after mulling the implications of a phase 3 fail, has given up on a late-stage kidney drug acquired in a $1 ...
CBS News on MSN
3d
Novo Nordisk's obesity-fighting drugs are fattening Denmark's economy while shrinking other sectors
Novo
Nordisk
's blockbuster drugs Ozempic and Wegovy have slimmed down Hollywood stars and millions of non-celebrities ...
STAT
20h
Novo Nordisk reports continued growth in obesity drug sales
Novo Nordisk shares were up Wednesday following an earnings report that showed continued sales growth of its obesity drug.
1d
Beasley: Q3 Earnings Snapshot
Beasley: Q3 Earnings Snapshot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Wegovy
semaglutide
United States
Ozempic
Catalent
Feedback